Scott Requadt, Chief Executive Officer at Talaris Therapeutics, Inc. (TALS), bought 8,618 shares at $4.24 ($37K) on 2022-07-26, disclosed to the SEC on 2022-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 5,528 | $23K | 64.1% |
| 2 | $4.25 | 3,090 | $13K | 35.9% |
| Total | $4.24 avg | 8,618 | $37K | 100% |
| Filing → |